94 related articles for article (PubMed ID: 8280607)
1. The inter-relationship of factor VII and its activity state with plasma lipids in healthy male adults.
Wright D; Poller L; Thomson JM; Gowland E; Burrows GE
Br J Haematol; 1993 Oct; 85(2):348-51. PubMed ID: 8280607
[TBL] [Abstract][Full Text] [Related]
2. Standardization of factor VII/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII.
Goudemand J; Caron C; Dreyfus M; Sié P;
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):505-11. PubMed ID: 12851539
[TBL] [Abstract][Full Text] [Related]
3. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease.
Hoffman CJ; Miller RH; Lawson WE; Hultin MB
J Am Coll Cardiol; 1989 Oct; 14(4):941-6. PubMed ID: 2794283
[TBL] [Abstract][Full Text] [Related]
4. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
5. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults.
Hoffman CJ; Lawson WE; Miller RH; Hultin MB
Arterioscler Thromb; 1994 Nov; 14(11):1737-40. PubMed ID: 7947597
[TBL] [Abstract][Full Text] [Related]
6. Elevation of factor VII activity and mass in coronary artery disease of varying severity.
Suzuki T; Yamauchi K; Matsushita T; Furumichi T; Furui H; Tsuzuki J; Saito H
Clin Cardiol; 1991 Sep; 14(9):731-6. PubMed ID: 1742907
[TBL] [Abstract][Full Text] [Related]
7. [Proconvertin activation in acute coronary disease. Preliminary results of a clinical and laboratory study].
de Sousa JC; Azevedo JG; Vicente O; Miguel MJ; Paulo A; Barros F; Ribeiro C; Parreira F
Rev Port Cardiol; 1988; 7(3):279-83. PubMed ID: 3273433
[No Abstract] [Full Text] [Related]
8. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults.
Hoffman CJ; Miller RH; Hultin MB
Arterioscler Thromb; 1992 Mar; 12(3):267-70. PubMed ID: 1547186
[TBL] [Abstract][Full Text] [Related]
9. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids.
Marckmann P; Sandström B; Jespersen J
Atherosclerosis; 1990 Jan; 80(3):227-33. PubMed ID: 2310428
[TBL] [Abstract][Full Text] [Related]
10. How to measure factor VII and factor VII activation.
Osterud B
Haemostasis; 1983; 13(3):161-8. PubMed ID: 6350121
[TBL] [Abstract][Full Text] [Related]
11. A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation.
Kitchen S; Malia RG; Greaves M; Preston FE
Thromb Res; 1988 Apr; 50(1):191-200. PubMed ID: 3400081
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Morrissey JH
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
[TBL] [Abstract][Full Text] [Related]
13. Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.
Nordøy A; Illingworth DR; Connor WE; Goodnight S
Haemostasis; 1990; 20(2):65-72. PubMed ID: 2347517
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of the factor VII rise during pregnancy.
Wright D; Poller L; Thomson JM; Sidebotham A; Hirst CF; Hirsch P
Thromb Haemost; 1998 Feb; 79(2):328-30. PubMed ID: 9493585
[TBL] [Abstract][Full Text] [Related]
15. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Sandset PM; Sirnes PA; Abildgaard U
Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
[TBL] [Abstract][Full Text] [Related]
16. Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
Mikami S; Tuddenham EG
Br J Haematol; 1986 Jan; 62(1):171-81. PubMed ID: 3484635
[TBL] [Abstract][Full Text] [Related]
17. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
[TBL] [Abstract][Full Text] [Related]
18. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease.
Miller GJ; Walter SJ; Stirling Y; Thompson SG; Esnouf MP; Meade TW
Br J Haematol; 1985 Feb; 59(2):249-58. PubMed ID: 3871629
[TBL] [Abstract][Full Text] [Related]
19. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia.
Bruckert E; Carvalho de Sousa J; Giral P; Soria C; Chapman MJ; Caen J; de Gennes JL
Atherosclerosis; 1989 Feb; 75(2-3):129-34. PubMed ID: 2712858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
